TG TherapeuticsTGTX
那斯達克 · USD
29.27
+0.24
(+0.83%)
收盤 03/07 04:59 (UTC+8)
盤後
29.40
+0.13
(+0.44%)
03/07 04:59 (UTC+8)
TG TherapeuticsTGTX
29.27
+0.24
(+0.83%)
財務數據
損益表
- 1.66
- 0.44
- 0.63
- 0.73
- 0.84
- 1.08
- 1.21
- 1.41
- 1.62
- 1.93
- 931.57
- -73.48
- 44.35
- 15.74
- 14.18
- 28.98
- 11.71
- 16.79
- 14.57
- 19.09
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 192,574 | 161,709 | 141,148 | 120,856 | 108,185 | 83,880 | 73,465 | 63,474 | 43,971 | 165,814 |
營業成本 | 38,142 | 28,093 | 18,938 | 15,541 | 15,399 | 9,342 | 8,304 | 5,441 | 7,854 | 3,509 |
營業毛利 | 154,432 | 133,616 | 122,210 | 105,315 | 92,786 | 74,538 | 65,161 | 58,033 | 36,117 | 162,305 |
營業費用 | 103,938 | 104,251 | 87,367 | - | 62,837 | 62,104 | 56,345 | - | 48,602 | 47,522 |
研發費用 | 41,193 | 40,878 | 31,782 | 46,362 | 23,874 | 20,139 | 17,556 | 32,722 | 17,449 | 14,752 |
推銷及管理費用 | 62,745 | 63,373 | 55,585 | 50,331 | 38,963 | 41,965 | 38,789 | 34,581 | 31,153 | 32,770 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 50,494 | 29,365 | 34,843 | 8,622 | 29,949 | 12,434 | 8,816 | -9,270 | -12,485 | 114,783 |
其他收入及費用 | 1,132 | 3,265 | 2,793 | 3,603 | 2,565 | 2,536 | 1,712 | 880 | 890 | 2,859 |
利息費用 | 6,533 | 6,721 | 6,716 | 6,757 | 7,061 | 10,702 | 3,977 | 2,288 | 2,431 | 3,713 |
稅前純益 | 45,093 | 25,909 | 30,920 | 5,468 | 25,453 | 4,268 | 6,551 | -10,678 | -14,026 | 113,929 |
所得稅 | 22,056 | -364,986 | 2,733 | 408 | 2,122 | 388 | -328 | 29 | 390 | - |
稅後純益 | 23,037 | 390,895 | 28,187 | 5,060 | 23,331 | 3,880 | 6,879 | -10,707 | -14,416 | 113,929 |
基本每股稅後盈餘(元) | 0.19 | 2.69 | 0.19 | 0.03 | 0.16 | 0.03 | 0.05 | -0.07 | -0.10 | 0.80 |
稀釋每股稅後盈餘(元) | 0.15 | 2.43 | 0.17 | 0.03 | 0.15 | 0.03 | 0.04 | -0.07 | -0.10 | 0.81 |
基本平均股數(千股) | 138435.00 | 145416.00 | 146739.00 | 146677.00 | 145243.00 | 145102.00 | 144727.00 | 146209.00 | 143092.00 | 142871.00 |
稀釋平均股數(千股) | 159325.00 | 160997.00 | 162559.00 | 162769.00 | 160244.00 | 160714.00 | 159423.00 | 146209.00 | 156091.00 | 155871.00 |
還原基本每股稅後盈餘(元) | 0.19 | 2.69 | 0.19 | 0.03 | 0.16 | 0.03 | 0.05 | -0.07 | -0.10 | 0.80 |
還原稀釋每股稅後盈餘(元) | 0.15 | 2.43 | 0.17 | 0.03 | 0.15 | 0.03 | 0.04 | -0.07 | -0.10 | 0.81 |
還原基本平均股數(千股) | 138,435 | 145,416 | 146,739 | 146,677 | 145,243 | 145,102 | 144,727 | 146,209 | 143,092 | 142,871 |
還原稀釋平均股數(千股) | 159,325 | 160,997 | 162,559 | 162,769 | 160,244 | 160,714 | 159,423 | 146,209 | 156,091 | 155,871 |
EBITDA(千元) | 51,614 | 32,210 | 36,716 | 11,249 | 31,182 | 13,631 | 9,439 | -9,339 | -12,397 | 118,190 |